We conclude that 3hi2one-G4 could be a useful pharmaceutical probe to study GIRK4 channel function and to optimize for treatment of GIRK4-specific channelopathies, such as hyperaldosteronism. The gene discussed is KCNJ5; the disease is hyperaldosteronism.